In Vitro Activity of Tebipenem, a New Oral Carbapenem Antibiotic, against β-Lactamase-Nonproducing, Ampicillin-Resistant Haemophilus influenzae

In vitro activity of tebipenem, a new oral carbapenem antibiotic, against clinical Haemophilus influenzae isolates was compared with those of 8 reference agents. Isolates were classified into 6 resistance classes after PCR identification of β-lactamase genes and ftsI gene mutations. For all isolates...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kishii, Kozue, Chiba, Naoko, Morozumi, Miyuki, Ono, Akiko, Ida, Takashi, Ubukata, Kimiko
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology (ASM) 2010
Gaiak:
Susceptibility
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2934951/
https://ncbi.nlm.nih.gov/pubmed/20585130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00054-10
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak